Canton, Eugene .
HRN: 23-94-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2023
CEFUROXIME 1.5GM (VIAL)
10/20/2023
10/23/2023
IV
1.5gm
Q8 3 Days
Post LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes